91 related articles for article (PubMed ID: 9784878)
1. [Structural organization of 2C-terminal region and its analogs in a subunit of ribonucleotide reductase from herpes virus].
Akhmedov NA; Abbasova GD; Abbasly RM; Akhmedov NF
Bioorg Khim; 1998 Aug; 24(8):586-92. PubMed ID: 9784878
[TBL] [Abstract][Full Text] [Related]
2. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
Lamarche N; Gaudreau P; Massie B; Langelier Y
Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
[TBL] [Abstract][Full Text] [Related]
3. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
Krogsrud RL; Welchner E; Scouten E; Liuzzi M
Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.
Gaudreau P; Michaud J; Cohen EA; Langelier Y; Brazeau P
J Biol Chem; 1987 Sep; 262(26):12413-6. PubMed ID: 3040743
[TBL] [Abstract][Full Text] [Related]
5. [Structural organization of rimorphin and its synthetic analogs].
Akhmedov NA; Makhmudova TA; Khalilov RI; Zeĭnalova NM
Bioorg Khim; 1995 Aug; 21(8):587-9. PubMed ID: 8540899
[TBL] [Abstract][Full Text] [Related]
6. Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation.
McClements W; Yamanaka G; Garsky V; Perry H; Bacchetti S; Colonno R; Stein RB
Virology; 1988 Jan; 162(1):270-3. PubMed ID: 2827385
[TBL] [Abstract][Full Text] [Related]
7. Ureido-based peptidomimetic inhibitor of herpes simplex virus ribonucleotide reductase: an investigation of inhibitor bioactive conformation.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Guse I; Llinàs-Brunet M; Plante R; Plamondon L; Wernic D; Déziel R
J Med Chem; 1996 May; 39(11):2178-87. PubMed ID: 8667361
[TBL] [Abstract][Full Text] [Related]
8. Influence of sequential oligopeptide carriers on the bioactive structure of conjugated epitopes: comparative study of the conformation of a Herpes simplex virus glycoprotein gD-1 epitope in the free and conjugated form, and protein "built-in" crystal structure.
Krikorian D; Stavrakoudis A; Biris N; Sakarellos C; Andreu D; de Oliveira E; Mezö G; Majer Z; Hudecz F; Welling-Wester S; Cung MT; Tsikaris V
Biopolymers; 2006; 84(4):383-99. PubMed ID: 16493659
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives.
Moss N; Déziel R; Adams J; Aubry N; Bailey M; Baillet M; Beaulieu P; DiMaio J; Duceppe JS; Ferland JM
J Med Chem; 1993 Oct; 36(20):3005-9. PubMed ID: 8411018
[TBL] [Abstract][Full Text] [Related]
10. Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.
Sun Y; Conner J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):97-104. PubMed ID: 10727407
[TBL] [Abstract][Full Text] [Related]
11. [Approach to the study of natural peptides from structure to functions. III. Structural organization of an adrenorphin molecule and its synthetic analogs].
Akhmedov NA; Makhmudova TA; Popov EM
Bioorg Khim; 1993 Jun; 19(6):623-8. PubMed ID: 8363653
[TBL] [Abstract][Full Text] [Related]
12. [Spatial structure of myelopeptides: I. Conformational analysis of MP-1, MP-2, and MP-3].
Akhmetov NA; Ismailova LI; Abbasly RM; Akhmedov NF; Godzhaev NM
Bioorg Khim; 2005; 31(1):31-8. PubMed ID: 15787211
[TBL] [Abstract][Full Text] [Related]
13. [Structure-functional organization of the secretin molecule. III. Reverse conformation problem].
Popov EM; Agaeva GA; Akhmedov NA
Mol Biol (Mosk); 1987; 21(1):182-8. PubMed ID: 3574303
[TBL] [Abstract][Full Text] [Related]
14. Identification of small peptides mimicking the R2 C-terminus of Mycobacterium tuberculosis ribonucleotide reductase.
Ericsson DJ; Nurbo J; Muthas D; Hertzberg K; Lindeberg G; Karlén A; Unge T
J Pept Sci; 2010 Mar; 16(3):159-64. PubMed ID: 20127854
[TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase inhibitors as anti-herpes agents.
Wnuk SF; Robins MJ
Antiviral Res; 2006 Sep; 71(2-3):122-6. PubMed ID: 16621038
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4'- azido-Phe6] HSV H2-6(6-15), to subunit 1.
Paradis H; Gaudreau P; Brazeau P; Langelier Y
J Biol Chem; 1988 Nov; 263(31):16045-50. PubMed ID: 2846533
[TBL] [Abstract][Full Text] [Related]
17. [Structure-activity organization of angiotensin II molecules. I. The structural problem].
Gogitidze TV; Popov EM
Bioorg Khim; 1993 May; 19(5):517-35. PubMed ID: 8318022
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and inhibitory potency of peptides corresponding to the subunit 2 C-terminal region of herpes virus ribonucleotide reductases.
Gaudreau P; Paradis H; Langelier Y; Brazeau P
J Med Chem; 1990 Feb; 33(2):723-30. PubMed ID: 2153825
[TBL] [Abstract][Full Text] [Related]
19. [Structure-function organization of the angiotensin II molecule. II. Reverse structural problem].
Gogitidze TV; Popov EM
Bioorg Khim; 1993 Jul; 19(7):693-703. PubMed ID: 8373449
[TBL] [Abstract][Full Text] [Related]
20. Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I.
Gaudreau P; Brazeau P; Richer M; Cormier J; Langlois D; Langelier Y
J Med Chem; 1992 Jan; 35(2):346-50. PubMed ID: 1310120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
